Actelion inks $360M deal to resolve DOJ kickbacks probe

An industrywide probe of pharma's charity contributions has spawned multimillion-dollar kickback settlements, and Actelion is the latest to make a deal with the feds.

The Johnson & Johnson unit inked a $360 million settlement on Thursday to wrap up allegations that its charity contributions served as kickbacks to boost use of its pulmonary arterial hypertension drugs. It's the largest settlement so far as the Department of Justice digs into a number of drugmakers' contributions to charities that help patients pay for their medications.